2024/03/28 18:00:03 | |
---|---|
Price | |
25.241 CHF | |
Difference | 0.62% (0.16) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 145,076 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 25.09 CHF (12,478) |
Ask (Ask size) | 25.166 CHF (12,478) |
Open | 25.117 CHF |
High | 25.241 CHF |
Low | 25.117 CHF |
Close (prev. day) | 25.085 CHF |
VWAP | 25.235095 CHF |
Volume (pcs) | 21 |
Trading volume | 529.90 |
Number of trades | 2 |
Last size | 20 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 18:00:03 | |
---|---|
Price | |
25.241 CHF | |
Difference | 0.62% (0.16) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 145,076 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 25.09 CHF (12,478) |
Ask (Ask size) | 25.166 CHF (12,478) |
Open | 25.117 CHF |
High | 25.241 CHF |
Low | 25.117 CHF |
Close (prev. day) | 25.085 CHF |
VWAP | 25.235095 CHF |
Volume (pcs) | 21 |
Trading volume | 529.90 |
Number of trades | 2 |
Last size | 20 |
6m | 1Y | 3Y | |
Perf (%) | -14.02% | -32.40% | - |
Perf (abs.) | -4.12 | -12.10 | - |
Beta | 0.15 | 0.33 | 0.41 |
Volatility | 28.48 | 27.68 | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 24.990 CHF (368) |
Ø price 30 days | Ø volume 30 days (pcs.) | 24.323 CHF (672) |
Ø price 100 days | Ø volume 100 days (pcs.) | 24.755 CHF (517) |
Ø price 250 days | Ø volume 250 days (pcs.) | 28.572 CHF (354) |
YTD High | date | 25.634 CHF (2024/01/03) |
YTD Low | date | 22.734 CHF (2024/03/05) |
52 Weeks High | date | 37.727 CHF (2023/04/04) |
52 Weeks Low | date | 22.734 CHF (2024/03/05) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/03/28 | 17:35 | 25.85 EUR | 2.52 | 263 |
Vienna Stock Exchange | 2024/03/28 | 17:32 | 25.80 EUR | 0.01 | 5 |
Tradegate | 2024/03/28 | 18:42 | 26.00 EUR | 2.54 | 291 |
Stuttgart | 2024/03/28 | 16:58 | 25.80 EUR | 0.04 | 9 |
NYSE | 2024/03/28 | 18:48 | 28.043 USD | 472.92 | 91,711 |
Munich | 2024/03/28 | 15:38 | 25.80 EUR | 0.01 | 3 |
London Stock Exchange | 2024/03/28 | 17:35 | 27.80 USD | 0.00 | 25 |
Hanover | 2024/03/28 | 08:37 | 25.60 EUR | 0.00 | 1 |
Hamburg | 2024/03/28 | 16:01 | 25.80 EUR | 0.03 | 3 |
Frankfurt | 2024/03/28 | 18:39 | 26.00 EUR | 0.35 | 30 |
Euronext Milan MTF Trading After Hours | 2024/03/27 | 19:06 | 25.80 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/03/28 | 17:44 | 25.85 EUR | 0.04 | 10 |
Duesseldorf | 2024/03/28 | 16:30 | 25.70 EUR | 0.01 | 5 |
Berlin | 2024/03/28 | 08:08 | 25.55 EUR | 0.00 | 1 |
BX Swiss | 2024/03/28 | 18:00 | 25.241 CHF | 0.00 | 2 |
PFIZER INC. |
- - |
66 Hudson Boulevard East - 10001-2192 New York |
Telefon: +1-212-733-2323 |
Fax: + |
E-mail: - |
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |
Dan Littman | Member of Board of Directors |
Helen Hobbs | Member of Board of Directors |
Scott Gottlieb | Member of Board of Directors |
Susan Desmond-Hellmann | Member of Board of Directors |
Susan Hockfield | Member of Board of Directors |
James Quincey | Member of Board of Directors |
James Smith | Member of Board of Directors |
Joseph Echevarria | Member of Board of Directors |
Ronald Blaylock | Member of Board of Directors |
Shantanu Narayen | Member of Board of Directors |
Suzanne Johnson | Member of Board of Directors |
Albert Bourla | Chairman of Managing Board |
Mikael Dolsten | Member of Executive Committee |
Rod MacKenzie | Member of Executive Committee |
Aamir Malik | Member of Executive Committee |
Angela Hwang | Member of Executive Committee |
Bill Carapezzi | Member of Executive Committee |
David M. Denton | Member of Executive Committee |
Doug Lankler | Member of Executive Committee |
Lidia Fonseca | Member of Executive Committee |
Mike McDermott | Member of Executive Committee |
Payal Sahni Becher | Member of Executive Committee |
Rady Johnson | Member of Executive Committee |
Sally Susman | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer